
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
          "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html>

<head>
    <meta http-equiv="Content-Type"
          content="text/html; charset=utf-8" />
    <title></title>
    <style type="text/css">
        table.diff {font-family: Menlo, Consolas, Monaco, Liberation Mono, Lucida Console, monospace; border:medium}
        .diff_header {background-color:#e0e0e0}
        td.diff_header {text-align:right}
        .diff_next {background-color:#c0c0c0}
        .diff_add {background-color:#aaffaa}
        .diff_chg {background-color:#ffff77}
        .diff_sub {background-color:#ffaaaa}
    </style>
</head>

<body>
    
    <table class="diff" id="difflib_chg_to16__top"
           cellspacing="0" cellpadding="0" rules="groups" >
        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>
        <colgroup></colgroup> <colgroup></colgroup> <colgroup></colgroup>
        <thead><tr><th class="diff_next"><br /></th><th colspan="2" class="diff_header">Original</th><th class="diff_next"><br /></th><th colspan="2" class="diff_header">Corrigido</th></tr></thead>
        <tbody>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__0">f</a></td><td class="diff_header" id="from16_1">1</td><td nowrap="nowrap">1.1.&nbsp;Trata-se&nbsp;da&nbsp;disponibilização&nbsp;da&nbsp;vacina&nbsp;hepatite&nbsp;A&nbsp;para&nbsp;público&nbsp;que&nbsp;faz</td><td class="diff_next"><a href="#difflib_chg_to16__0">f</a></td><td class="diff_header" id="to16_1">1</td><td nowrap="nowrap">1.1.&nbsp;Trata-se&nbsp;da&nbsp;disponibilização&nbsp;da&nbsp;vacina&nbsp;hepatite&nbsp;A&nbsp;para&nbsp;público&nbsp;que&nbsp;faz</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_2">2</td><td nowrap="nowrap">uso&nbsp;da&nbsp;profilaxia&nbsp;pré-exposição&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HIV&nbsp;(PrEP).</td><td class="diff_next"></td><td class="diff_header" id="to16_2">2</td><td nowrap="nowrap">uso&nbsp;da&nbsp;profilaxia&nbsp;pré-exposição&nbsp;de&nbsp;infecção&nbsp;pelo&nbsp;HIV&nbsp;(PrEP).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_3">3</td><td nowrap="nowrap">2.&nbsp;CONTEXTO</td><td class="diff_next"></td><td class="diff_header" id="to16_3">3</td><td nowrap="nowrap">2.&nbsp;CONTEXTO</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_4">4</td><td nowrap="nowrap">2.1.&nbsp;A&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;uma&nbsp;inflamação&nbsp;no&nbsp;fígado&nbsp;causada&nbsp;por&nbsp;uma&nbsp;infecção&nbsp;viral,</td><td class="diff_next"></td><td class="diff_header" id="to16_4">4</td><td nowrap="nowrap">2.1.&nbsp;A&nbsp;hepatite&nbsp;A&nbsp;é&nbsp;uma&nbsp;inflamação&nbsp;no&nbsp;fígado&nbsp;causada&nbsp;por&nbsp;uma&nbsp;infecção&nbsp;viral,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_5">5</td><td nowrap="nowrap">que&nbsp;pode&nbsp;resultar&nbsp;em&nbsp;complicações,&nbsp;geralmente&nbsp;autolimitadas.&nbsp;Ao&nbsp;contrário&nbsp;das</td><td class="diff_next"></td><td class="diff_header" id="to16_5">5</td><td nowrap="nowrap">que&nbsp;pode&nbsp;resultar&nbsp;em&nbsp;complicações,&nbsp;geralmente&nbsp;autolimitadas.&nbsp;Ao&nbsp;contrário&nbsp;das</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_6">6</td><td nowrap="nowrap">hepatites&nbsp;B&nbsp;e&nbsp;C,&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;não&nbsp;evolui&nbsp;para&nbsp;cronificação,&nbsp;mas&nbsp;pode&nbsp;causar</td><td class="diff_next"></td><td class="diff_header" id="to16_6">6</td><td nowrap="nowrap">hepatites&nbsp;B&nbsp;e&nbsp;C,&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;não&nbsp;evolui&nbsp;para&nbsp;cronificação,&nbsp;mas&nbsp;pode&nbsp;causar</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_7">7</td><td nowrap="nowrap">sintomas&nbsp;debilitantes&nbsp;e,&nbsp;raramente,&nbsp;falência&nbsp;hepática&nbsp;aguda&nbsp;(fatal).&nbsp;Mundialmente,&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_7">7</td><td nowrap="nowrap">sintomas&nbsp;debilitantes&nbsp;e,&nbsp;raramente,&nbsp;falência&nbsp;hepática&nbsp;aguda&nbsp;(fatal).&nbsp;Mundialmente,&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_8">8</td><td nowrap="nowrap">Organização&nbsp;Mundial&nbsp;de&nbsp;Saúde&nbsp;(OMS)&nbsp;estima&nbsp;que,&nbsp;em&nbsp;2016,&nbsp;7.134&nbsp;pessoas&nbsp;foram&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_8">8</td><td nowrap="nowrap">Organização&nbsp;Mundial&nbsp;de&nbsp;Saúde&nbsp;(OMS)&nbsp;estima&nbsp;que,&nbsp;em&nbsp;2016,&nbsp;7.134&nbsp;pessoas&nbsp;foram&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_9">9</td><td nowrap="nowrap">óbito&nbsp;por&nbsp;hepatite&nbsp;A&nbsp;(WHO,&nbsp;2023).</td><td class="diff_next"></td><td class="diff_header" id="to16_9">9</td><td nowrap="nowrap">óbito&nbsp;por&nbsp;hepatite&nbsp;A&nbsp;(WHO,&nbsp;2023).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_10">10</td><td nowrap="nowrap">2.2.&nbsp;A&nbsp;transmissão&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)&nbsp;ocorre&nbsp;predominantemente</td><td class="diff_next"></td><td class="diff_header" id="to16_10">10</td><td nowrap="nowrap">2.2.&nbsp;A&nbsp;transmissão&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;(HAV)&nbsp;ocorre&nbsp;predominantemente</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_11">11</td><td nowrap="nowrap">por&nbsp;via&nbsp;fecal-oral,&nbsp;podendo&nbsp;acontecer&nbsp;através&nbsp;da&nbsp;ingestão&nbsp;de&nbsp;água&nbsp;ou&nbsp;alimentos</td><td class="diff_next"></td><td class="diff_header" id="to16_11">11</td><td nowrap="nowrap">por&nbsp;via&nbsp;fecal-oral,&nbsp;podendo&nbsp;acontecer&nbsp;através&nbsp;da&nbsp;ingestão&nbsp;de&nbsp;água&nbsp;ou&nbsp;alimentos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_12">12</td><td nowrap="nowrap">contaminados,&nbsp;bem&nbsp;como&nbsp;por&nbsp;meio&nbsp;de&nbsp;práticas&nbsp;sexuais&nbsp;que&nbsp;envolvem&nbsp;contato&nbsp;oro-</td><td class="diff_next"></td><td class="diff_header" id="to16_12">12</td><td nowrap="nowrap">contaminados,&nbsp;bem&nbsp;como&nbsp;por&nbsp;meio&nbsp;de&nbsp;práticas&nbsp;sexuais&nbsp;que&nbsp;envolvem&nbsp;contato&nbsp;oro-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_13">13</td><td nowrap="nowrap">anal.&nbsp;A&nbsp;via&nbsp;sexual&nbsp;de&nbsp;transmissão&nbsp;tem&nbsp;sido&nbsp;mais&nbsp;prevalente&nbsp;em&nbsp;populações&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to16_13">13</td><td nowrap="nowrap">anal.&nbsp;A&nbsp;via&nbsp;sexual&nbsp;de&nbsp;transmissão&nbsp;tem&nbsp;sido&nbsp;mais&nbsp;prevalente&nbsp;em&nbsp;populações&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_14">14</td><td nowrap="nowrap">situação&nbsp;de&nbsp;maior&nbsp;vulnerabilidade,&nbsp;como&nbsp;gays&nbsp;e&nbsp;outros&nbsp;homens&nbsp;que&nbsp;fazem&nbsp;sexo&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to16_14">14</td><td nowrap="nowrap">situação&nbsp;de&nbsp;maior&nbsp;vulnerabilidade,&nbsp;como&nbsp;gays&nbsp;e&nbsp;outros&nbsp;homens&nbsp;que&nbsp;fazem&nbsp;sexo&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_15">15</td><td nowrap="nowrap">homens&nbsp;(HSH),&nbsp;além&nbsp;de&nbsp;pessoas&nbsp;que&nbsp;utilizam&nbsp;drogas,&nbsp;especialmente&nbsp;aquelas&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to16_15">15</td><td nowrap="nowrap">homens&nbsp;(HSH),&nbsp;além&nbsp;de&nbsp;pessoas&nbsp;que&nbsp;utilizam&nbsp;drogas,&nbsp;especialmente&nbsp;aquelas&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_16">16</td><td nowrap="nowrap">compartilham&nbsp;utensílios&nbsp;para&nbsp;consumo.</td><td class="diff_next"></td><td class="diff_header" id="to16_16">16</td><td nowrap="nowrap">compartilham&nbsp;utensílios&nbsp;para&nbsp;consumo.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_17">17</td><td nowrap="nowrap">2.3.&nbsp;Nesse&nbsp;contexto,&nbsp;surtos&nbsp;da&nbsp;doença&nbsp;têm&nbsp;sido&nbsp;relatados&nbsp;na&nbsp;população</td><td class="diff_next"></td><td class="diff_header" id="to16_17">17</td><td nowrap="nowrap">2.3.&nbsp;Nesse&nbsp;contexto,&nbsp;surtos&nbsp;da&nbsp;doença&nbsp;têm&nbsp;sido&nbsp;relatados&nbsp;na&nbsp;população</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_18">18</td><td nowrap="nowrap">adulta,&nbsp;com&nbsp;dados&nbsp;epidemiológicos&nbsp;evidenciando&nbsp;uma&nbsp;predominância&nbsp;de&nbsp;casos&nbsp;entre</td><td class="diff_next"></td><td class="diff_header" id="to16_18">18</td><td nowrap="nowrap">adulta,&nbsp;com&nbsp;dados&nbsp;epidemiológicos&nbsp;evidenciando&nbsp;uma&nbsp;predominância&nbsp;de&nbsp;casos&nbsp;entre</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_19">19</td><td nowrap="nowrap">homens&nbsp;que&nbsp;fazem&nbsp;sexo&nbsp;com&nbsp;homens&nbsp;(HSH).&nbsp;Um&nbsp;exemplo&nbsp;disso&nbsp;ocorreu&nbsp;em&nbsp;São</td><td class="diff_next"></td><td class="diff_header" id="to16_19">19</td><td nowrap="nowrap">homens&nbsp;que&nbsp;fazem&nbsp;sexo&nbsp;com&nbsp;homens&nbsp;(HSH).&nbsp;Um&nbsp;exemplo&nbsp;disso&nbsp;ocorreu&nbsp;em&nbsp;São</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_20">20</td><td nowrap="nowrap">Paulo,&nbsp;em&nbsp;2018,&nbsp;conforme&nbsp;apontado&nbsp;por&nbsp;documentos&nbsp;oficiais,&nbsp;como&nbsp;a&nbsp;Nota</td><td class="diff_next"></td><td class="diff_header" id="to16_20">20</td><td nowrap="nowrap">Paulo,&nbsp;em&nbsp;2018,&nbsp;conforme&nbsp;apontado&nbsp;por&nbsp;documentos&nbsp;oficiais,&nbsp;como&nbsp;a&nbsp;Nota</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_21">21</td><td nowrap="nowrap">Informativa&nbsp;nº&nbsp;10/2018&nbsp;COVIG/CGVP/DIAHV/SVS/MS&nbsp;e&nbsp;a&nbsp;Nota&nbsp;Técnica&nbsp;Nº&nbsp;1/2024-</td><td class="diff_next"></td><td class="diff_header" id="to16_21">21</td><td nowrap="nowrap">Informativa&nbsp;nº&nbsp;10/2018&nbsp;COVIG/CGVP/DIAHV/SVS/MS&nbsp;e&nbsp;a&nbsp;Nota&nbsp;Técnica&nbsp;Nº&nbsp;1/2024-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_22">22</td><td nowrap="nowrap">CGHV/DATHI/SVSA/MS.</td><td class="diff_next"></td><td class="diff_header" id="to16_22">22</td><td nowrap="nowrap">CGHV/DATHI/SVSA/MS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_23">23</td><td nowrap="nowrap">2.4.&nbsp;Diante&nbsp;desse&nbsp;perfil&nbsp;epidemiológico&nbsp;e&nbsp;da&nbsp;forma&nbsp;de&nbsp;transmissão&nbsp;do&nbsp;vírus,&nbsp;é</td><td class="diff_next"></td><td class="diff_header" id="to16_23">23</td><td nowrap="nowrap">2.4.&nbsp;Diante&nbsp;desse&nbsp;perfil&nbsp;epidemiológico&nbsp;e&nbsp;da&nbsp;forma&nbsp;de&nbsp;transmissão&nbsp;do&nbsp;vírus,&nbsp;é</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_24">24</td><td nowrap="nowrap">importante&nbsp;destacar&nbsp;que&nbsp;pessoas&nbsp;que&nbsp;fazem&nbsp;uso&nbsp;da&nbsp;profilaxia&nbsp;pré-exposição&nbsp;à</td><td class="diff_next"></td><td class="diff_header" id="to16_24">24</td><td nowrap="nowrap">importante&nbsp;destacar&nbsp;que&nbsp;pessoas&nbsp;que&nbsp;fazem&nbsp;uso&nbsp;da&nbsp;profilaxia&nbsp;pré-exposição&nbsp;à</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_25">25</td><td nowrap="nowrap">infecção&nbsp;pelo&nbsp;HIV&nbsp;(PrEP)&nbsp;podem&nbsp;apresentar&nbsp;um&nbsp;risco&nbsp;aumentado&nbsp;para&nbsp;a&nbsp;aquisição&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to16_25">25</td><td nowrap="nowrap">infecção&nbsp;pelo&nbsp;HIV&nbsp;(PrEP)&nbsp;podem&nbsp;apresentar&nbsp;um&nbsp;risco&nbsp;aumentado&nbsp;para&nbsp;a&nbsp;aquisição&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_26">26</td><td nowrap="nowrap">hepatite&nbsp;A,&nbsp;especialmente&nbsp;devido&nbsp;à&nbsp;possibilidade&nbsp;de&nbsp;contato&nbsp;oro-anal&nbsp;durante&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_26">26</td><td nowrap="nowrap">hepatite&nbsp;A,&nbsp;especialmente&nbsp;devido&nbsp;à&nbsp;possibilidade&nbsp;de&nbsp;contato&nbsp;oro-anal&nbsp;durante&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_27">27</td><td nowrap="nowrap">atividade&nbsp;sexual.</td><td class="diff_next"></td><td class="diff_header" id="to16_27">27</td><td nowrap="nowrap">atividade&nbsp;sexual.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_28">28</td><td nowrap="nowrap">2.5.&nbsp;A&nbsp;PrEP&nbsp;é&nbsp;uma&nbsp;medida&nbsp;preventiva&nbsp;efetiva&nbsp;na&nbsp;redução&nbsp;da&nbsp;transmissão&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to16_28">28</td><td nowrap="nowrap">2.5.&nbsp;A&nbsp;PrEP&nbsp;é&nbsp;uma&nbsp;medida&nbsp;preventiva&nbsp;efetiva&nbsp;na&nbsp;redução&nbsp;da&nbsp;transmissão&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_29">29</td><td nowrap="nowrap">HIV,&nbsp;recomendada&nbsp;para&nbsp;pessoas&nbsp;em&nbsp;maior&nbsp;risco&nbsp;de&nbsp;infecção.&nbsp;Considerando&nbsp;que</td><td class="diff_next"></td><td class="diff_header" id="to16_29">29</td><td nowrap="nowrap">HIV,&nbsp;recomendada&nbsp;para&nbsp;pessoas&nbsp;em&nbsp;maior&nbsp;risco&nbsp;de&nbsp;infecção.&nbsp;Considerando&nbsp;que</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_30">30</td><td nowrap="nowrap">usuários&nbsp;com&nbsp;indicação&nbsp;de&nbsp;PrEP&nbsp;apresentam,&nbsp;desproporcionalmente,&nbsp;maiores&nbsp;taxas</td><td class="diff_next"></td><td class="diff_header" id="to16_30">30</td><td nowrap="nowrap">usuários&nbsp;com&nbsp;indicação&nbsp;de&nbsp;PrEP&nbsp;apresentam,&nbsp;desproporcionalmente,&nbsp;maiores&nbsp;taxas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_31">31</td><td nowrap="nowrap">de&nbsp;HAV,&nbsp;a&nbsp;inclusão&nbsp;da&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;para&nbsp;esses&nbsp;usuários&nbsp;visa&nbsp;ampliar&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_31">31</td><td nowrap="nowrap">de&nbsp;HAV,&nbsp;a&nbsp;inclusão&nbsp;da&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;para&nbsp;esses&nbsp;usuários&nbsp;visa&nbsp;ampliar&nbsp;a</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__0"></td><td class="diff_header" id="from16_32">32</td><td nowrap="nowrap">cobertura&nbsp;vacinal&nbsp;e&nbsp;reduzir&nbsp;as&nbsp;consequências&nbsp;potencialmente&nbsp;nesta&nbsp;população.</td><td class="diff_next"></td><td class="diff_header" id="to16_32">32</td><td nowrap="nowrap">cobertura&nbsp;vacinal&nbsp;e&nbsp;reduzir&nbsp;as&nbsp;consequências&nbsp;potencialmente&nbsp;nesta&nbsp;população.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_33">33</td><td nowrap="nowrap">3.&nbsp;RECOMENDAÇÃO</td><td class="diff_next"></td><td class="diff_header" id="to16_33">33</td><td nowrap="nowrap">3.&nbsp;RECOMENDAÇÃO</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_34">34</td><td nowrap="nowrap">3.1.&nbsp;A&nbsp;vacinação&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;em&nbsp;usuários&nbsp;de&nbsp;PrEP&nbsp;deve&nbsp;ser&nbsp;realizada</td><td class="diff_next"></td><td class="diff_header" id="to16_34">34</td><td nowrap="nowrap">3.1.&nbsp;A&nbsp;vacinação&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;em&nbsp;usuários&nbsp;de&nbsp;PrEP&nbsp;deve&nbsp;ser&nbsp;realizada</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_35">35</td><td nowrap="nowrap">em&nbsp;esquema&nbsp;de&nbsp;duas&nbsp;doses,&nbsp;aplicadas&nbsp;por&nbsp;via&nbsp;intramuscular&nbsp;(IM).&nbsp;Essa</td><td class="diff_next"></td><td class="diff_header" id="to16_35">35</td><td nowrap="nowrap">em&nbsp;esquema&nbsp;de&nbsp;duas&nbsp;doses,&nbsp;aplicadas&nbsp;por&nbsp;via&nbsp;intramuscular&nbsp;(IM).&nbsp;Essa</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_36">36</td><td nowrap="nowrap">recomendação&nbsp;baseia-se&nbsp;na&nbsp;observação&nbsp;de&nbsp;uma&nbsp;possível&nbsp;redução&nbsp;na&nbsp;resposta</td><td class="diff_next"></td><td class="diff_header" id="to16_36">36</td><td nowrap="nowrap">recomendação&nbsp;baseia-se&nbsp;na&nbsp;observação&nbsp;de&nbsp;uma&nbsp;possível&nbsp;redução&nbsp;na&nbsp;resposta</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__1">n</a></td><td class="diff_header" id="from16_37">37</td><td nowrap="nowrap"><span class="diff_sub">Nota&nbsp;Técnica&nbsp;Conjunta&nbsp;184&nbsp;(0047447082)&nbsp;SEI&nbsp;25000.061286/2025-97&nbsp;/&nbsp;pg.&nbsp;1</span></td><td class="diff_next"><a href="#difflib_chg_to16__1">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_38">38</td><td nowrap="nowrap">imunológica&nbsp;nessa&nbsp;população,&nbsp;o&nbsp;que&nbsp;contribui&nbsp;para&nbsp;uma&nbsp;maior&nbsp;vulnerabilidade&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_37">37</td><td nowrap="nowrap">imunológica&nbsp;nessa&nbsp;população,&nbsp;o&nbsp;que&nbsp;contribui&nbsp;para&nbsp;uma&nbsp;maior&nbsp;vulnerabilidade&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_39">39</td><td nowrap="nowrap">infecções&nbsp;sexualmente&nbsp;transmissíveis.&nbsp;Dessa&nbsp;forma,&nbsp;a&nbsp;vacinação&nbsp;é&nbsp;uma&nbsp;medida</td><td class="diff_next"></td><td class="diff_header" id="to16_38">38</td><td nowrap="nowrap">infecções&nbsp;sexualmente&nbsp;transmissíveis.&nbsp;Dessa&nbsp;forma,&nbsp;a&nbsp;vacinação&nbsp;é&nbsp;uma&nbsp;medida</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_40">40</td><td nowrap="nowrap">preventiva&nbsp;essencial&nbsp;para&nbsp;garantir&nbsp;a&nbsp;saúde&nbsp;e&nbsp;o&nbsp;bem-estar&nbsp;desses&nbsp;usuários.</td><td class="diff_next"></td><td class="diff_header" id="to16_39">39</td><td nowrap="nowrap">preventiva&nbsp;essencial&nbsp;para&nbsp;garantir&nbsp;a&nbsp;saúde&nbsp;e&nbsp;o&nbsp;bem-estar&nbsp;desses&nbsp;usuários.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_41">41</td><td nowrap="nowrap">A&nbsp;vacinação&nbsp;será&nbsp;realizada&nbsp;conforme&nbsp;os&nbsp;seguintes&nbsp;critérios:</td><td class="diff_next"></td><td class="diff_header" id="to16_40">40</td><td nowrap="nowrap">A&nbsp;vacinação&nbsp;será&nbsp;realizada&nbsp;conforme&nbsp;os&nbsp;seguintes&nbsp;critérios:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_42">42</td><td nowrap="nowrap">Usuários&nbsp;(as)&nbsp;sem&nbsp;comprovação&nbsp;vacinal:&nbsp;Vacinar&nbsp;com&nbsp;duas&nbsp;doses,</td><td class="diff_next"></td><td class="diff_header" id="to16_41">41</td><td nowrap="nowrap">Usuários&nbsp;(as)&nbsp;sem&nbsp;comprovação&nbsp;vacinal:&nbsp;Vacinar&nbsp;com&nbsp;duas&nbsp;doses,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_43">43</td><td nowrap="nowrap">conforme&nbsp;faixa&nbsp;etária,&nbsp;utilizando&nbsp;intervalo&nbsp;mínimo&nbsp;de&nbsp;6&nbsp;meses</td><td class="diff_next"></td><td class="diff_header" id="to16_42">42</td><td nowrap="nowrap">conforme&nbsp;faixa&nbsp;etária,&nbsp;utilizando&nbsp;intervalo&nbsp;mínimo&nbsp;de&nbsp;6&nbsp;meses</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_44">44</td><td nowrap="nowrap">entre&nbsp;as&nbsp;doses.</td><td class="diff_next"></td><td class="diff_header" id="to16_43">43</td><td nowrap="nowrap">entre&nbsp;as&nbsp;doses.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_45">45</td><td nowrap="nowrap">Usuários&nbsp;(as)&nbsp;com&nbsp;comprovação&nbsp;vacinal&nbsp;(duas&nbsp;doses):&nbsp;Não&nbsp;vacinar.</td><td class="diff_next"></td><td class="diff_header" id="to16_44">44</td><td nowrap="nowrap">Usuários&nbsp;(as)&nbsp;com&nbsp;comprovação&nbsp;vacinal&nbsp;(duas&nbsp;doses):&nbsp;Não&nbsp;vacinar.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_46">46</td><td nowrap="nowrap">Usuários&nbsp;(as)&nbsp;com&nbsp;comprovação&nbsp;vacinal&nbsp;(uma&nbsp;dose):&nbsp;Vacinar&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to16_45">45</td><td nowrap="nowrap">Usuários&nbsp;(as)&nbsp;com&nbsp;comprovação&nbsp;vacinal&nbsp;(uma&nbsp;dose):&nbsp;Vacinar&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_47">47</td><td nowrap="nowrap">mais&nbsp;uma&nbsp;dose,&nbsp;conforme&nbsp;faixa&nbsp;etária.</td><td class="diff_next"></td><td class="diff_header" id="to16_46">46</td><td nowrap="nowrap">mais&nbsp;uma&nbsp;dose,&nbsp;conforme&nbsp;faixa&nbsp;etária.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_48">48</td><td nowrap="nowrap">Usuários&nbsp;(as)&nbsp;com&nbsp;comprovação&nbsp;sorológica&nbsp;(anti-HAV&nbsp;total&nbsp;ou&nbsp;anti-</td><td class="diff_next"></td><td class="diff_header" id="to16_47">47</td><td nowrap="nowrap">Usuários&nbsp;(as)&nbsp;com&nbsp;comprovação&nbsp;sorológica&nbsp;(anti-HAV&nbsp;total&nbsp;ou&nbsp;anti-</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_49">49</td><td nowrap="nowrap">HAV&nbsp;IgG&nbsp;reagente(s):&nbsp;Não&nbsp;vacinar.</td><td class="diff_next"></td><td class="diff_header" id="to16_48">48</td><td nowrap="nowrap">HAV&nbsp;IgG&nbsp;reagente(s):&nbsp;Não&nbsp;vacinar.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_50">50</td><td nowrap="nowrap">3.2.&nbsp;Para&nbsp;a&nbsp;faixa&nbsp;etária&nbsp;de&nbsp;15&nbsp;a&nbsp;17&nbsp;anos&nbsp;deve&nbsp;ser&nbsp;utilizada&nbsp;a&nbsp;vacina&nbsp;pediátrica</td><td class="diff_next"></td><td class="diff_header" id="to16_49">49</td><td nowrap="nowrap">3.2.&nbsp;Para&nbsp;a&nbsp;faixa&nbsp;etária&nbsp;de&nbsp;15&nbsp;a&nbsp;17&nbsp;anos&nbsp;deve&nbsp;ser&nbsp;utilizada&nbsp;a&nbsp;vacina&nbsp;pediátrica</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_51">51</td><td nowrap="nowrap">na&nbsp;dose&nbsp;de&nbsp;0,5&nbsp;mL&nbsp;(a&nbsp;cada&nbsp;dose&nbsp;aplicada).&nbsp;Para&nbsp;usuários&nbsp;com&nbsp;idade&nbsp;≥&nbsp;18&nbsp;anos</td><td class="diff_next"></td><td class="diff_header" id="to16_50">50</td><td nowrap="nowrap">na&nbsp;dose&nbsp;de&nbsp;0,5&nbsp;mL&nbsp;(a&nbsp;cada&nbsp;dose&nbsp;aplicada).&nbsp;Para&nbsp;usuários&nbsp;com&nbsp;idade&nbsp;≥&nbsp;18&nbsp;anos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_52">52</td><td nowrap="nowrap">utilizar&nbsp;a&nbsp;vacina&nbsp;de&nbsp;uso&nbsp;adulto&nbsp;na&nbsp;dose&nbsp;de&nbsp;1,0&nbsp;mL&nbsp;(a&nbsp;cada&nbsp;dose&nbsp;aplicada).</td><td class="diff_next"></td><td class="diff_header" id="to16_51">51</td><td nowrap="nowrap">utilizar&nbsp;a&nbsp;vacina&nbsp;de&nbsp;uso&nbsp;adulto&nbsp;na&nbsp;dose&nbsp;de&nbsp;1,0&nbsp;mL&nbsp;(a&nbsp;cada&nbsp;dose&nbsp;aplicada).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_53">53</td><td nowrap="nowrap">3.3.&nbsp;Vale&nbsp;esclarecer&nbsp;que&nbsp;a&nbsp;vacina&nbsp;está&nbsp;contraindicada&nbsp;para&nbsp;usuários&nbsp;com</td><td class="diff_next"></td><td class="diff_header" id="to16_52">52</td><td nowrap="nowrap">3.3.&nbsp;Vale&nbsp;esclarecer&nbsp;que&nbsp;a&nbsp;vacina&nbsp;está&nbsp;contraindicada&nbsp;para&nbsp;usuários&nbsp;com</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_54">54</td><td nowrap="nowrap">histórico&nbsp;de&nbsp;reação&nbsp;anafilática&nbsp;a&nbsp;algum&nbsp;dos&nbsp;componentes&nbsp;da&nbsp;formulação.&nbsp;Os&nbsp;efeitos</td><td class="diff_next"></td><td class="diff_header" id="to16_53">53</td><td nowrap="nowrap">histórico&nbsp;de&nbsp;reação&nbsp;anafilática&nbsp;a&nbsp;algum&nbsp;dos&nbsp;componentes&nbsp;da&nbsp;formulação.&nbsp;Os&nbsp;efeitos</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_55">55</td><td nowrap="nowrap">adversos&nbsp;relacionados&nbsp;à&nbsp;vacina&nbsp;podem&nbsp;ser&nbsp;locais&nbsp;(dor,&nbsp;eritema,&nbsp;edema)&nbsp;ou</td><td class="diff_next"></td><td class="diff_header" id="to16_54">54</td><td nowrap="nowrap">adversos&nbsp;relacionados&nbsp;à&nbsp;vacina&nbsp;podem&nbsp;ser&nbsp;locais&nbsp;(dor,&nbsp;eritema,&nbsp;edema)&nbsp;ou</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_56">56</td><td nowrap="nowrap">sistêmicos&nbsp;(febre&nbsp;e&nbsp;fadiga)&nbsp;(BRASIL,&nbsp;2023).</td><td class="diff_next"></td><td class="diff_header" id="to16_55">55</td><td nowrap="nowrap">sistêmicos&nbsp;(febre&nbsp;e&nbsp;fadiga)&nbsp;(BRASIL,&nbsp;2023).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_57">57</td><td nowrap="nowrap">3.4.&nbsp;Usuários&nbsp;(as)&nbsp;da&nbsp;PrEP&nbsp;que,&nbsp;durante&nbsp;o&nbsp;período&nbsp;de&nbsp;surto,&nbsp;receberam&nbsp;apenas</td><td class="diff_next"></td><td class="diff_header" id="to16_56">56</td><td nowrap="nowrap">3.4.&nbsp;Usuários&nbsp;(as)&nbsp;da&nbsp;PrEP&nbsp;que,&nbsp;durante&nbsp;o&nbsp;período&nbsp;de&nbsp;surto,&nbsp;receberam&nbsp;apenas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_58">58</td><td nowrap="nowrap">uma&nbsp;dose&nbsp;da&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;devem&nbsp;ser&nbsp;orientados&nbsp;a&nbsp;comparecer,&nbsp;o</td><td class="diff_next"></td><td class="diff_header" id="to16_57">57</td><td nowrap="nowrap">uma&nbsp;dose&nbsp;da&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A&nbsp;devem&nbsp;ser&nbsp;orientados&nbsp;a&nbsp;comparecer,&nbsp;o</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_59">59</td><td nowrap="nowrap">quanto&nbsp;antes,&nbsp;às&nbsp;unidades&nbsp;de&nbsp;saúde&nbsp;para&nbsp;receber&nbsp;a&nbsp;segunda&nbsp;dose&nbsp;recomendada,&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_58">58</td><td nowrap="nowrap">quanto&nbsp;antes,&nbsp;às&nbsp;unidades&nbsp;de&nbsp;saúde&nbsp;para&nbsp;receber&nbsp;a&nbsp;segunda&nbsp;dose&nbsp;recomendada,&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_60">60</td><td nowrap="nowrap">fim&nbsp;de&nbsp;completar&nbsp;o&nbsp;esquema&nbsp;vacinal&nbsp;e&nbsp;garantir&nbsp;proteção&nbsp;imunológica&nbsp;adequada.</td><td class="diff_next"></td><td class="diff_header" id="to16_59">59</td><td nowrap="nowrap">fim&nbsp;de&nbsp;completar&nbsp;o&nbsp;esquema&nbsp;vacinal&nbsp;e&nbsp;garantir&nbsp;proteção&nbsp;imunológica&nbsp;adequada.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_61">61</td><td nowrap="nowrap">3.5.&nbsp;Destaca-se&nbsp;que&nbsp;a&nbsp;não&nbsp;disponibilidade&nbsp;da&nbsp;sorologia&nbsp;para&nbsp;pesquisa&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to16_60">60</td><td nowrap="nowrap">3.5.&nbsp;Destaca-se&nbsp;que&nbsp;a&nbsp;não&nbsp;disponibilidade&nbsp;da&nbsp;sorologia&nbsp;para&nbsp;pesquisa&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_62">62</td><td nowrap="nowrap">anticorpos&nbsp;anti-HAV&nbsp;não&nbsp;deve&nbsp;ser&nbsp;impeditiva&nbsp;para&nbsp;a&nbsp;vacinação&nbsp;do&nbsp;usuário&nbsp;de&nbsp;PrEP.</td><td class="diff_next"></td><td class="diff_header" id="to16_61">61</td><td nowrap="nowrap">anticorpos&nbsp;anti-HAV&nbsp;não&nbsp;deve&nbsp;ser&nbsp;impeditiva&nbsp;para&nbsp;a&nbsp;vacinação&nbsp;do&nbsp;usuário&nbsp;de&nbsp;PrEP.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_63">63</td><td nowrap="nowrap">Assim,&nbsp;caso&nbsp;a&nbsp;Rede&nbsp;de&nbsp;Atenção&nbsp;à&nbsp;Saúde&nbsp;não&nbsp;disponha&nbsp;dessa&nbsp;sorologia,&nbsp;deve-se</td><td class="diff_next"></td><td class="diff_header" id="to16_62">62</td><td nowrap="nowrap">Assim,&nbsp;caso&nbsp;a&nbsp;Rede&nbsp;de&nbsp;Atenção&nbsp;à&nbsp;Saúde&nbsp;não&nbsp;disponha&nbsp;dessa&nbsp;sorologia,&nbsp;deve-se</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_64">64</td><td nowrap="nowrap">proceder&nbsp;à&nbsp;vacinação&nbsp;para&nbsp;a&nbsp;hepatite&nbsp;A,&nbsp;aproveitando&nbsp;a&nbsp;oportunidade&nbsp;da&nbsp;consulta&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to16_63">63</td><td nowrap="nowrap">proceder&nbsp;à&nbsp;vacinação&nbsp;para&nbsp;a&nbsp;hepatite&nbsp;A,&nbsp;aproveitando&nbsp;a&nbsp;oportunidade&nbsp;da&nbsp;consulta&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_65">65</td><td nowrap="nowrap">evitando&nbsp;a&nbsp;perda&nbsp;de&nbsp;seguimento&nbsp;do&nbsp;usuário.</td><td class="diff_next"></td><td class="diff_header" id="to16_64">64</td><td nowrap="nowrap">evitando&nbsp;a&nbsp;perda&nbsp;de&nbsp;seguimento&nbsp;do&nbsp;usuário.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_66">66</td><td nowrap="nowrap">3.6.&nbsp;Não&nbsp;é&nbsp;necessária&nbsp;validação&nbsp;especializada,&nbsp;a&nbsp;apresentação&nbsp;da&nbsp;receita&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to16_65">65</td><td nowrap="nowrap">3.6.&nbsp;Não&nbsp;é&nbsp;necessária&nbsp;validação&nbsp;especializada,&nbsp;a&nbsp;apresentação&nbsp;da&nbsp;receita&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_67">67</td><td nowrap="nowrap">PrEP&nbsp;é&nbsp;suficiente&nbsp;para&nbsp;comprovar&nbsp;a&nbsp;indicação.&nbsp;Como&nbsp;sugestão&nbsp;aos&nbsp;prescritores,</td><td class="diff_next"></td><td class="diff_header" id="to16_66">66</td><td nowrap="nowrap">PrEP&nbsp;é&nbsp;suficiente&nbsp;para&nbsp;comprovar&nbsp;a&nbsp;indicação.&nbsp;Como&nbsp;sugestão&nbsp;aos&nbsp;prescritores,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_68">68</td><td nowrap="nowrap">pode-se&nbsp;utilizar&nbsp;o&nbsp;formulário&nbsp;de&nbsp;“Prescrição&nbsp;de&nbsp;Imunizantes”,&nbsp;disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to16_67">67</td><td nowrap="nowrap">pode-se&nbsp;utilizar&nbsp;o&nbsp;formulário&nbsp;de&nbsp;“Prescrição&nbsp;de&nbsp;Imunizantes”,&nbsp;disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_69">69</td><td nowrap="nowrap">3.7.&nbsp;A&nbsp;vacina&nbsp;deve&nbsp;ser&nbsp;garantida&nbsp;a&nbsp;todos&nbsp;os&nbsp;usuários&nbsp;de&nbsp;PrEP,&nbsp;conforme&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_68">68</td><td nowrap="nowrap">3.7.&nbsp;A&nbsp;vacina&nbsp;deve&nbsp;ser&nbsp;garantida&nbsp;a&nbsp;todos&nbsp;os&nbsp;usuários&nbsp;de&nbsp;PrEP,&nbsp;conforme&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_70">70</td><td nowrap="nowrap">Portaria&nbsp;GM/MS&nbsp;nº&nbsp;6.623/2025,&nbsp;que&nbsp;regula&nbsp;a&nbsp;Rede&nbsp;de&nbsp;Imunobiológicos&nbsp;para&nbsp;Pessoas</td><td class="diff_next"></td><td class="diff_header" id="to16_69">69</td><td nowrap="nowrap">Portaria&nbsp;GM/MS&nbsp;nº&nbsp;6.623/2025,&nbsp;que&nbsp;regula&nbsp;a&nbsp;Rede&nbsp;de&nbsp;Imunobiológicos&nbsp;para&nbsp;Pessoas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_71">71</td><td nowrap="nowrap">com&nbsp;Situações&nbsp;Especiais&nbsp;(RIE).&nbsp;Pode&nbsp;ser&nbsp;solicitada&nbsp;em&nbsp;qualquer&nbsp;sala&nbsp;de&nbsp;vacina</td><td class="diff_next"></td><td class="diff_header" id="to16_70">70</td><td nowrap="nowrap">com&nbsp;Situações&nbsp;Especiais&nbsp;(RIE).&nbsp;Pode&nbsp;ser&nbsp;solicitada&nbsp;em&nbsp;qualquer&nbsp;sala&nbsp;de&nbsp;vacina</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_72">72</td><td nowrap="nowrap">Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imunobiológicos&nbsp;Especiais&nbsp;(CRIE),&nbsp;Centros&nbsp;Intermediários</td><td class="diff_next"></td><td class="diff_header" id="to16_71">71</td><td nowrap="nowrap">Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imunobiológicos&nbsp;Especiais&nbsp;(CRIE),&nbsp;Centros&nbsp;Intermediários</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_73">73</td><td nowrap="nowrap">de&nbsp;Imunobiológicos&nbsp;Especiais&nbsp;(CIIE)&nbsp;e&nbsp;em&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;públicas&nbsp;habilitadas.&nbsp;Assim,</td><td class="diff_next"></td><td class="diff_header" id="to16_72">72</td><td nowrap="nowrap">de&nbsp;Imunobiológicos&nbsp;Especiais&nbsp;(CIIE)&nbsp;e&nbsp;em&nbsp;salas&nbsp;de&nbsp;vacina&nbsp;públicas&nbsp;habilitadas.&nbsp;Assim,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_74">74</td><td nowrap="nowrap">a&nbsp;vacina&nbsp;pode&nbsp;ser&nbsp;realizada&nbsp;em&nbsp;qualquer&nbsp;serviço&nbsp;integrado&nbsp;à&nbsp;RIE,&nbsp;a&nbsp;depender&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to16_73">73</td><td nowrap="nowrap">a&nbsp;vacina&nbsp;pode&nbsp;ser&nbsp;realizada&nbsp;em&nbsp;qualquer&nbsp;serviço&nbsp;integrado&nbsp;à&nbsp;RIE,&nbsp;a&nbsp;depender&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_75">75</td><td nowrap="nowrap">organização&nbsp;local.</td><td class="diff_next"></td><td class="diff_header" id="to16_74">74</td><td nowrap="nowrap">organização&nbsp;local.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__1"></td><td class="diff_header" id="from16_76">76</td><td nowrap="nowrap">3.8.&nbsp;Destaca-se&nbsp;a&nbsp;importância&nbsp;das&nbsp;ações&nbsp;de&nbsp;comunicação&nbsp;para&nbsp;profissionais</td><td class="diff_next"></td><td class="diff_header" id="to16_75">75</td><td nowrap="nowrap">3.8.&nbsp;Destaca-se&nbsp;a&nbsp;importância&nbsp;das&nbsp;ações&nbsp;de&nbsp;comunicação&nbsp;para&nbsp;profissionais</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_77">77</td><td nowrap="nowrap">de&nbsp;saúde,&nbsp;gestores&nbsp;e&nbsp;sociedade&nbsp;civil,&nbsp;garantindo&nbsp;ampliação&nbsp;do&nbsp;acesso&nbsp;à&nbsp;vacinação</td><td class="diff_next"></td><td class="diff_header" id="to16_76">76</td><td nowrap="nowrap">de&nbsp;saúde,&nbsp;gestores&nbsp;e&nbsp;sociedade&nbsp;civil,&nbsp;garantindo&nbsp;ampliação&nbsp;do&nbsp;acesso&nbsp;à&nbsp;vacinação</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__2"></td><td class="diff_header" id="from16_78">78</td><td nowrap="nowrap">contra&nbsp;hepatite&nbsp;A&nbsp;pelos&nbsp;usuários&nbsp;de&nbsp;PrEP,&nbsp;redução&nbsp;da&nbsp;desinformação&nbsp;e&nbsp;hesitação</td><td class="diff_next"></td><td class="diff_header" id="to16_77">77</td><td nowrap="nowrap">contra&nbsp;hepatite&nbsp;A&nbsp;pelos&nbsp;usuários&nbsp;de&nbsp;PrEP,&nbsp;redução&nbsp;da&nbsp;desinformação&nbsp;e&nbsp;hesitação</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_79">79</td><td nowrap="nowrap">vacinal.</td><td class="diff_next"></td><td class="diff_header" id="to16_78">78</td><td nowrap="nowrap">vacinal.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_80">80</td><td nowrap="nowrap">4.&nbsp;OPERACIONALIZAÇÃO</td><td class="diff_next"></td><td class="diff_header" id="to16_79">79</td><td nowrap="nowrap">4.&nbsp;OPERACIONALIZAÇÃO</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__2">n</a></td><td class="diff_header" id="from16_81">81</td><td nowrap="nowrap">4.1.&nbsp;A&nbsp;vacina&nbsp;Hepatite&nbsp;A&nbsp;<span class="diff_chg">–</span>&nbsp;uso&nbsp;adulto,&nbsp;no&nbsp;SUS,&nbsp;é&nbsp;disponibilizada&nbsp;para&nbsp;pessoas</td><td class="diff_next"><a href="#difflib_chg_to16__2">n</a></td><td class="diff_header" id="to16_80">80</td><td nowrap="nowrap">4.1.&nbsp;A&nbsp;vacina&nbsp;Hepatite&nbsp;A&nbsp;<span class="diff_chg">-</span>&nbsp;uso&nbsp;adulto,&nbsp;no&nbsp;SUS,&nbsp;é&nbsp;disponibilizada&nbsp;para&nbsp;pessoas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_82">82</td><td nowrap="nowrap">com&nbsp;situações&nbsp;clínicas&nbsp;especiais&nbsp;de&nbsp;morbidade&nbsp;e&nbsp;de&nbsp;risco&nbsp;à&nbsp;saúde,&nbsp;nos&nbsp;serviços&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to16_81">81</td><td nowrap="nowrap">com&nbsp;situações&nbsp;clínicas&nbsp;especiais&nbsp;de&nbsp;morbidade&nbsp;e&nbsp;de&nbsp;risco&nbsp;à&nbsp;saúde,&nbsp;nos&nbsp;serviços&nbsp;da</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__3">n</a></td><td class="diff_header" id="from16_83">83</td><td nowrap="nowrap"><span class="diff_sub">Nota&nbsp;Técnica&nbsp;Conjunta&nbsp;184&nbsp;(0047447082)&nbsp;SEI&nbsp;25000.061286/2025-97&nbsp;/&nbsp;pg.&nbsp;2</span></td><td class="diff_next"><a href="#difflib_chg_to16__3">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_84">84</td><td nowrap="nowrap">“Rede&nbsp;de&nbsp;Imunobiológicos&nbsp;para&nbsp;Pessoas&nbsp;com&nbsp;Situações&nbsp;Especiais&nbsp;(RIE)&nbsp;”.</td><td class="diff_next"></td><td class="diff_header" id="to16_82">82</td><td nowrap="nowrap">“Rede&nbsp;de&nbsp;Imunobiológicos&nbsp;para&nbsp;Pessoas&nbsp;com&nbsp;Situações&nbsp;Especiais&nbsp;(RIE)&nbsp;”.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_85">85</td><td nowrap="nowrap">4.2.&nbsp;Nesse&nbsp;sentido,&nbsp;a&nbsp;vacinação&nbsp;para&nbsp;usuários&nbsp;que&nbsp;fazem&nbsp;uso&nbsp;da&nbsp;profilaxia</td><td class="diff_next"></td><td class="diff_header" id="to16_83">83</td><td nowrap="nowrap">4.2.&nbsp;Nesse&nbsp;sentido,&nbsp;a&nbsp;vacinação&nbsp;para&nbsp;usuários&nbsp;que&nbsp;fazem&nbsp;uso&nbsp;da&nbsp;profilaxia</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_86">86</td><td nowrap="nowrap">pré-exposição&nbsp;de&nbsp;risco&nbsp;à&nbsp;infecção&nbsp;pelo&nbsp;HIV&nbsp;(PrEP)&nbsp;poderá&nbsp;ser&nbsp;realizada&nbsp;em&nbsp;todos&nbsp;os</td><td class="diff_next"></td><td class="diff_header" id="to16_84">84</td><td nowrap="nowrap">pré-exposição&nbsp;de&nbsp;risco&nbsp;à&nbsp;infecção&nbsp;pelo&nbsp;HIV&nbsp;(PrEP)&nbsp;poderá&nbsp;ser&nbsp;realizada&nbsp;em&nbsp;todos&nbsp;os</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_87">87</td><td nowrap="nowrap">serviços&nbsp;integrados&nbsp;à&nbsp;RIE,&nbsp;de&nbsp;acordo&nbsp;com&nbsp;a&nbsp;organização&nbsp;do&nbsp;serviço.</td><td class="diff_next"></td><td class="diff_header" id="to16_85">85</td><td nowrap="nowrap">serviços&nbsp;integrados&nbsp;à&nbsp;RIE,&nbsp;de&nbsp;acordo&nbsp;com&nbsp;a&nbsp;organização&nbsp;do&nbsp;serviço.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_88">88</td><td nowrap="nowrap">4.3.&nbsp;Para&nbsp;tanto,&nbsp;ressalta-se&nbsp;a&nbsp;importância&nbsp;da&nbsp;promoção&nbsp;de&nbsp;ações&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to16_86">86</td><td nowrap="nowrap">4.3.&nbsp;Para&nbsp;tanto,&nbsp;ressalta-se&nbsp;a&nbsp;importância&nbsp;da&nbsp;promoção&nbsp;de&nbsp;ações&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_89">89</td><td nowrap="nowrap">comunicação&nbsp;efetiva&nbsp;dessa&nbsp;nova&nbsp;recomendação&nbsp;junto&nbsp;aos&nbsp;profissionais&nbsp;de&nbsp;saúde,</td><td class="diff_next"></td><td class="diff_header" id="to16_87">87</td><td nowrap="nowrap">comunicação&nbsp;efetiva&nbsp;dessa&nbsp;nova&nbsp;recomendação&nbsp;junto&nbsp;aos&nbsp;profissionais&nbsp;de&nbsp;saúde,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_90">90</td><td nowrap="nowrap">gestores&nbsp;e&nbsp;organizações&nbsp;da&nbsp;sociedade&nbsp;civil,&nbsp;de&nbsp;modo&nbsp;a&nbsp;possibilitar&nbsp;a&nbsp;ampliação&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to16_88">88</td><td nowrap="nowrap">gestores&nbsp;e&nbsp;organizações&nbsp;da&nbsp;sociedade&nbsp;civil,&nbsp;de&nbsp;modo&nbsp;a&nbsp;possibilitar&nbsp;a&nbsp;ampliação&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_91">91</td><td nowrap="nowrap">acesso&nbsp;ao&nbsp;público-alvo,&nbsp;em&nbsp;conformidade&nbsp;com&nbsp;as&nbsp;diretrizes&nbsp;do&nbsp;SUS,&nbsp;mitigando&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_89">89</td><td nowrap="nowrap">acesso&nbsp;ao&nbsp;público-alvo,&nbsp;em&nbsp;conformidade&nbsp;com&nbsp;as&nbsp;diretrizes&nbsp;do&nbsp;SUS,&nbsp;mitigando&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_92">92</td><td nowrap="nowrap">desinformação&nbsp;e&nbsp;a&nbsp;hesitação&nbsp;vacinal.</td><td class="diff_next"></td><td class="diff_header" id="to16_90">90</td><td nowrap="nowrap">desinformação&nbsp;e&nbsp;a&nbsp;hesitação&nbsp;vacinal.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_93">93</td><td nowrap="nowrap">5.&nbsp;ORIENTAÇÃO&nbsp;PARA&nbsp;REGISTRO&nbsp;DE&nbsp;DOSES&nbsp;APLICADAS</td><td class="diff_next"></td><td class="diff_header" id="to16_91">91</td><td nowrap="nowrap">5.&nbsp;ORIENTAÇÃO&nbsp;PARA&nbsp;REGISTRO&nbsp;DE&nbsp;DOSES&nbsp;APLICADAS</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_94">94</td><td nowrap="nowrap">5.1.&nbsp;Os&nbsp;registros&nbsp;das&nbsp;doses&nbsp;aplicadas&nbsp;da&nbsp;vacina&nbsp;hepatite&nbsp;A&nbsp;deverão&nbsp;ser&nbsp;feitas</td><td class="diff_next"></td><td class="diff_header" id="to16_92">92</td><td nowrap="nowrap">5.1.&nbsp;Os&nbsp;registros&nbsp;das&nbsp;doses&nbsp;aplicadas&nbsp;da&nbsp;vacina&nbsp;hepatite&nbsp;A&nbsp;deverão&nbsp;ser&nbsp;feitas</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_95">95</td><td nowrap="nowrap">no&nbsp;SIPNI,&nbsp;no&nbsp;e-SUS&nbsp;APS&nbsp;ou&nbsp;em&nbsp;sistemas&nbsp;próprios&nbsp;ou&nbsp;terceiros&nbsp;integrados&nbsp;com&nbsp;à</td><td class="diff_next"></td><td class="diff_header" id="to16_93">93</td><td nowrap="nowrap">no&nbsp;SIPNI,&nbsp;no&nbsp;e-SUS&nbsp;APS&nbsp;ou&nbsp;em&nbsp;sistemas&nbsp;próprios&nbsp;ou&nbsp;terceiros&nbsp;integrados&nbsp;com&nbsp;à</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_96">96</td><td nowrap="nowrap">RNDS.</td><td class="diff_next"></td><td class="diff_header" id="to16_94">94</td><td nowrap="nowrap">RNDS.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_97">97</td><td nowrap="nowrap">5.2.&nbsp;O&nbsp;registro&nbsp;da&nbsp;dose&nbsp;aplicada&nbsp;deverá&nbsp;garantir&nbsp;a&nbsp;identificação&nbsp;do&nbsp;cidadão</td><td class="diff_next"></td><td class="diff_header" id="to16_95">95</td><td nowrap="nowrap">5.2.&nbsp;O&nbsp;registro&nbsp;da&nbsp;dose&nbsp;aplicada&nbsp;deverá&nbsp;garantir&nbsp;a&nbsp;identificação&nbsp;do&nbsp;cidadão</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_98">98</td><td nowrap="nowrap">vacinado&nbsp;pelo&nbsp;número&nbsp;do&nbsp;Cadastro&nbsp;de&nbsp;Pessoa&nbsp;Física&nbsp;(CPF)&nbsp;ou&nbsp;do&nbsp;Cartão&nbsp;Nacional&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to16_96">96</td><td nowrap="nowrap">vacinado&nbsp;pelo&nbsp;número&nbsp;do&nbsp;Cadastro&nbsp;de&nbsp;Pessoa&nbsp;Física&nbsp;(CPF)&nbsp;ou&nbsp;do&nbsp;Cartão&nbsp;Nacional&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_99">99</td><td nowrap="nowrap">Saúde&nbsp;(CNS).</td><td class="diff_next"></td><td class="diff_header" id="to16_97">97</td><td nowrap="nowrap">Saúde&nbsp;(CNS).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_100">100</td><td nowrap="nowrap">5.3.&nbsp;Deve-se&nbsp;observar&nbsp;se&nbsp;o&nbsp;CPF&nbsp;ou&nbsp;o&nbsp;CNS&nbsp;foram&nbsp;devidamente&nbsp;validados&nbsp;no</td><td class="diff_next"></td><td class="diff_header" id="to16_98">98</td><td nowrap="nowrap">5.3.&nbsp;Deve-se&nbsp;observar&nbsp;se&nbsp;o&nbsp;CPF&nbsp;ou&nbsp;o&nbsp;CNS&nbsp;foram&nbsp;devidamente&nbsp;validados&nbsp;no</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_101">101</td><td nowrap="nowrap">Sistema&nbsp;de&nbsp;Cadastramento&nbsp;de&nbsp;Usuários&nbsp;do&nbsp;SUS&nbsp;(CADSUS).</td><td class="diff_next"></td><td class="diff_header" id="to16_99">99</td><td nowrap="nowrap">Sistema&nbsp;de&nbsp;Cadastramento&nbsp;de&nbsp;Usuários&nbsp;do&nbsp;SUS&nbsp;(CADSUS).</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_102">102</td><td nowrap="nowrap">5.4.&nbsp;O&nbsp;registro&nbsp;da&nbsp;dose&nbsp;aplicada&nbsp;deverá&nbsp;garantir,&nbsp;também,&nbsp;a&nbsp;identificação&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to16_100">100</td><td nowrap="nowrap">5.4.&nbsp;O&nbsp;registro&nbsp;da&nbsp;dose&nbsp;aplicada&nbsp;deverá&nbsp;garantir,&nbsp;também,&nbsp;a&nbsp;identificação&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_103">103</td><td nowrap="nowrap">vacina,&nbsp;do&nbsp;lote,&nbsp;do&nbsp;fabricante&nbsp;e&nbsp;da&nbsp;dose&nbsp;aplicada.</td><td class="diff_next"></td><td class="diff_header" id="to16_101">101</td><td nowrap="nowrap">vacina,&nbsp;do&nbsp;lote,&nbsp;do&nbsp;fabricante&nbsp;e&nbsp;da&nbsp;dose&nbsp;aplicada.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_104">104</td><td nowrap="nowrap">registrada&nbsp;na&nbsp;estratégia&nbsp;especial,&nbsp;como&nbsp;D1&nbsp;e&nbsp;D2,&nbsp;com&nbsp;o&nbsp;seguinte&nbsp;CID:</td><td class="diff_next"></td><td class="diff_header" id="to16_102">102</td><td nowrap="nowrap">registrada&nbsp;na&nbsp;estratégia&nbsp;especial,&nbsp;como&nbsp;D1&nbsp;e&nbsp;D2,&nbsp;com&nbsp;o&nbsp;seguinte&nbsp;CID:</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_105">105</td><td nowrap="nowrap">Para&nbsp;usuários&nbsp;de&nbsp;PrEP:&nbsp;CID&nbsp;10&nbsp;-&nbsp;Z268&nbsp;(Necessidade&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to16_103">103</td><td nowrap="nowrap">Para&nbsp;usuários&nbsp;de&nbsp;PrEP:&nbsp;CID&nbsp;10&nbsp;-&nbsp;Z268&nbsp;(Necessidade&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_106">106</td><td nowrap="nowrap">únicas)</td><td class="diff_next"></td><td class="diff_header" id="to16_104">104</td><td nowrap="nowrap">únicas)</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_107">107</td><td nowrap="nowrap">atendimento&nbsp;FAIXA&nbsp;ETÁRIA&nbsp;e&nbsp;Especialidade&nbsp;ENFERMEIRO.</td><td class="diff_next"></td><td class="diff_header" id="to16_105">105</td><td nowrap="nowrap">atendimento&nbsp;FAIXA&nbsp;ETÁRIA&nbsp;e&nbsp;Especialidade&nbsp;ENFERMEIRO.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_108">108</td><td nowrap="nowrap">Registros&nbsp;realizados&nbsp;no&nbsp;e-SUS&nbsp;APS&nbsp;utilizar&nbsp;o&nbsp;grupo&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to16_106">106</td><td nowrap="nowrap">Registros&nbsp;realizados&nbsp;no&nbsp;e-SUS&nbsp;APS&nbsp;utilizar&nbsp;o&nbsp;grupo&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_109">109</td><td nowrap="nowrap">atendimento&nbsp;FAIXA&nbsp;ETÁRIA.</td><td class="diff_next"></td><td class="diff_header" id="to16_107">107</td><td nowrap="nowrap">atendimento&nbsp;FAIXA&nbsp;ETÁRIA.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_110">110</td><td nowrap="nowrap">6.&nbsp;CONSIDERAÇÕES&nbsp;FINAIS</td><td class="diff_next"></td><td class="diff_header" id="to16_108">108</td><td nowrap="nowrap">6.&nbsp;CONSIDERAÇÕES&nbsp;FINAIS</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_111">111</td><td nowrap="nowrap">6.1.&nbsp;A&nbsp;partir&nbsp;da&nbsp;publicação&nbsp;desta&nbsp;nota&nbsp;técnica,&nbsp;a&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A</td><td class="diff_next"></td><td class="diff_header" id="to16_109">109</td><td nowrap="nowrap">6.1.&nbsp;A&nbsp;partir&nbsp;da&nbsp;publicação&nbsp;desta&nbsp;nota&nbsp;técnica,&nbsp;a&nbsp;vacina&nbsp;contra&nbsp;a&nbsp;hepatite&nbsp;A</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_112">112</td><td nowrap="nowrap">passa&nbsp;a&nbsp;ser&nbsp;ofertada&nbsp;pelo&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;usuários&nbsp;(as)&nbsp;de&nbsp;PrEP.</td><td class="diff_next"></td><td class="diff_header" id="to16_110">110</td><td nowrap="nowrap">passa&nbsp;a&nbsp;ser&nbsp;ofertada&nbsp;pelo&nbsp;Sistema&nbsp;Único&nbsp;de&nbsp;Saúde&nbsp;(SUS)&nbsp;para&nbsp;usuários&nbsp;(as)&nbsp;de&nbsp;PrEP.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_113">113</td><td nowrap="nowrap">Espera-se&nbsp;que&nbsp;essa&nbsp;ampliação&nbsp;contribua&nbsp;para&nbsp;evitar&nbsp;novos&nbsp;surtos&nbsp;e&nbsp;mitigar&nbsp;a</td><td class="diff_next"></td><td class="diff_header" id="to16_111">111</td><td nowrap="nowrap">Espera-se&nbsp;que&nbsp;essa&nbsp;ampliação&nbsp;contribua&nbsp;para&nbsp;evitar&nbsp;novos&nbsp;surtos&nbsp;e&nbsp;mitigar&nbsp;a</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_114">114</td><td nowrap="nowrap">propagação&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A,&nbsp;promovendo&nbsp;a&nbsp;melhoria&nbsp;das&nbsp;condições&nbsp;de&nbsp;saúde</td><td class="diff_next"></td><td class="diff_header" id="to16_112">112</td><td nowrap="nowrap">propagação&nbsp;do&nbsp;vírus&nbsp;da&nbsp;hepatite&nbsp;A,&nbsp;promovendo&nbsp;a&nbsp;melhoria&nbsp;das&nbsp;condições&nbsp;de&nbsp;saúde</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__3"></td><td class="diff_header" id="from16_115">115</td><td nowrap="nowrap">coletiva&nbsp;e&nbsp;a&nbsp;eliminação&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;na&nbsp;comunidade.</td><td class="diff_next"></td><td class="diff_header" id="to16_113">113</td><td nowrap="nowrap">coletiva&nbsp;e&nbsp;a&nbsp;eliminação&nbsp;da&nbsp;hepatite&nbsp;A&nbsp;na&nbsp;comunidade.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_116">116</td><td nowrap="nowrap">6.2.&nbsp;Diante&nbsp;do&nbsp;exposto,&nbsp;colocamo-nos&nbsp;à&nbsp;disposição&nbsp;para&nbsp;fornecer&nbsp;quaisquer</td><td class="diff_next"></td><td class="diff_header" id="to16_114">114</td><td nowrap="nowrap">6.2.&nbsp;Diante&nbsp;do&nbsp;exposto,&nbsp;colocamo-nos&nbsp;à&nbsp;disposição&nbsp;para&nbsp;fornecer&nbsp;quaisquer</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_117">117</td><td nowrap="nowrap">informações&nbsp;adicionais&nbsp;que&nbsp;se&nbsp;fizerem&nbsp;necessárias.</td><td class="diff_next"></td><td class="diff_header" id="to16_115">115</td><td nowrap="nowrap">informações&nbsp;adicionais&nbsp;que&nbsp;se&nbsp;fizerem&nbsp;necessárias.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_118">118</td><td nowrap="nowrap">7.&nbsp;REFERÊNCIAS</td><td class="diff_next"></td><td class="diff_header" id="to16_116">116</td><td nowrap="nowrap">7.&nbsp;REFERÊNCIAS</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__4"></td><td class="diff_header" id="from16_119">119</td><td nowrap="nowrap">World&nbsp;Health&nbsp;Organisation.&nbsp;Hepatitis&nbsp;A.&nbsp;20&nbsp;July&nbsp;2023.&nbsp;Disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to16_117">117</td><td nowrap="nowrap">World&nbsp;Health&nbsp;Organisation.&nbsp;Hepatitis&nbsp;A.&nbsp;20&nbsp;July&nbsp;2023.&nbsp;Disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__4">n</a></td><td class="diff_header" id="from16_120">120</td><td nowrap="nowrap"><span class="diff_sub">&lt;https://www.who.int/news-room/fact-sheets/detail/hepatitis-a&gt;&nbsp;Acesso&nbsp;em</span></td><td class="diff_next"><a href="#difflib_chg_to16__4">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_121">121</td><td nowrap="nowrap">08/01/2025.</td><td class="diff_next"></td><td class="diff_header" id="to16_118">118</td><td nowrap="nowrap">08/01/2025.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_122">122</td><td nowrap="nowrap">Brasil.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde&nbsp;e&nbsp;Ambiente.</td><td class="diff_next"></td><td class="diff_header" id="to16_119">119</td><td nowrap="nowrap">Brasil.&nbsp;Ministério&nbsp;da&nbsp;Saúde.&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde&nbsp;e&nbsp;Ambiente.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__5"></td><td class="diff_header" id="from16_123">123</td><td nowrap="nowrap">Transmissíveis.&nbsp;Boletim&nbsp;Epidemiológico&nbsp;Hepatites&nbsp;Virais,&nbsp;2024.&nbsp;Disponível&nbsp;em:</td><td class="diff_next"></td><td class="diff_header" id="to16_120">120</td><td nowrap="nowrap">Transmissíveis.&nbsp;Boletim&nbsp;Epidemiológico&nbsp;Hepatites&nbsp;Virais,&nbsp;2024.&nbsp;Disponível&nbsp;em:</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__5">n</a></td><td class="diff_header" id="from16_124">124</td><td nowrap="nowrap"><span class="diff_sub">Nota&nbsp;Técnica&nbsp;Conjunta&nbsp;184&nbsp;(0047447082)&nbsp;SEI&nbsp;25000.061286/2025-97&nbsp;/&nbsp;pg.&nbsp;3</span></td><td class="diff_next"><a href="#difflib_chg_to16__5">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__6"></td><td class="diff_header" id="from16_125">125</td><td nowrap="nowrap">epidemiologicos/2024/boletim-epidemiologico-hepatites-virais-2024/view&nbsp;&gt;&nbsp;Acesso</td><td class="diff_next"></td><td class="diff_header" id="to16_121">121</td><td nowrap="nowrap">epidemiologicos/2024/boletim-epidemiologico-hepatites-virais-2024/view&nbsp;&gt;&nbsp;Acesso</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_126">126</td><td nowrap="nowrap">em&nbsp;08/01/2025.</td><td class="diff_next"></td><td class="diff_header" id="to16_122">122</td><td nowrap="nowrap">em&nbsp;08/01/2025.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_127">127</td><td nowrap="nowrap">WORD&nbsp;HEALTH&nbsp;ORGANIZATION,&nbsp;2017.&nbsp;Hepatitis&nbsp;A&nbsp;outbreaks&nbsp;mostly&nbsp;affecting&nbsp;men</td><td class="diff_next"></td><td class="diff_header" id="to16_123">123</td><td nowrap="nowrap">WORD&nbsp;HEALTH&nbsp;ORGANIZATION,&nbsp;2017.&nbsp;Hepatitis&nbsp;A&nbsp;outbreaks&nbsp;mostly&nbsp;affecting&nbsp;men</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__6">n</a></td><td class="diff_header" id="from16_128">128</td><td nowrap="nowrap">who&nbsp;have&nbsp;sex&nbsp;with&nbsp;men&nbsp;<span class="diff_chg">–</span>&nbsp;European&nbsp;Region&nbsp;and&nbsp;the&nbsp;Americas.</td><td class="diff_next"><a href="#difflib_chg_to16__6">n</a></td><td class="diff_header" id="to16_124">124</td><td nowrap="nowrap">who&nbsp;have&nbsp;sex&nbsp;with&nbsp;men&nbsp;<span class="diff_chg">-</span>&nbsp;European&nbsp;Region&nbsp;and&nbsp;the&nbsp;Americas.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_129">129</td><td nowrap="nowrap">men-who-have-sex-with-men-european-region-and-the-americas</td><td class="diff_next"></td><td class="diff_header" id="to16_125">125</td><td nowrap="nowrap">men-who-have-sex-with-men-european-region-and-the-americas</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__7">n</a></td><td class="diff_header" id="from16_130">130</td><td nowrap="nowrap">SÃO&nbsp;PAULO&nbsp;(Município)&nbsp;<span class="diff_chg">–</span>&nbsp;Secretaria&nbsp;Municipal&nbsp;de&nbsp;Saúde.&nbsp;Coordenação&nbsp;de&nbsp;Vigilância</td><td class="diff_next"><a href="#difflib_chg_to16__7">n</a></td><td class="diff_header" id="to16_126">126</td><td nowrap="nowrap">SÃO&nbsp;PAULO&nbsp;(Município)&nbsp;<span class="diff_chg">-</span>&nbsp;Secretaria&nbsp;Municipal&nbsp;de&nbsp;Saúde.&nbsp;Coordenação&nbsp;de&nbsp;Vigilância</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_131">131</td><td nowrap="nowrap">em&nbsp;Saúde.&nbsp;Projeto&nbsp;de&nbsp;Intervenção&nbsp;Implementação&nbsp;de&nbsp;estratégias&nbsp;para&nbsp;ampliação&nbsp;da</td><td class="diff_next"></td><td class="diff_header" id="to16_127">127</td><td nowrap="nowrap">em&nbsp;Saúde.&nbsp;Projeto&nbsp;de&nbsp;Intervenção&nbsp;Implementação&nbsp;de&nbsp;estratégias&nbsp;para&nbsp;ampliação&nbsp;da</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_132">132</td><td nowrap="nowrap">cobertura&nbsp;vacinal&nbsp;no&nbsp;território&nbsp;brasileiro,&nbsp;considerando&nbsp;peculiaridades&nbsp;regionais&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to16_128">128</td><td nowrap="nowrap">cobertura&nbsp;vacinal&nbsp;no&nbsp;território&nbsp;brasileiro,&nbsp;considerando&nbsp;peculiaridades&nbsp;regionais&nbsp;e</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_133">133</td><td nowrap="nowrap">populacionais.&nbsp;São&nbsp;Paulo,&nbsp;2018.&nbsp;Dados&nbsp;não&nbsp;publicados,&nbsp;cedidos&nbsp;pela&nbsp;Vigilância</td><td class="diff_next"></td><td class="diff_header" id="to16_129">129</td><td nowrap="nowrap">populacionais.&nbsp;São&nbsp;Paulo,&nbsp;2018.&nbsp;Dados&nbsp;não&nbsp;publicados,&nbsp;cedidos&nbsp;pela&nbsp;Vigilância</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__7"></td><td class="diff_header" id="from16_134">134</td><td nowrap="nowrap">Epidemiológica&nbsp;de&nbsp;Doenças&nbsp;Transmitidas&nbsp;por&nbsp;Alimentos&nbsp;(VEDTA)&nbsp;-&nbsp;Núcleo&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to16_130">130</td><td nowrap="nowrap">Epidemiológica&nbsp;de&nbsp;Doenças&nbsp;Transmitidas&nbsp;por&nbsp;Alimentos&nbsp;(VEDTA)&nbsp;-&nbsp;Núcleo&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_135">135</td><td nowrap="nowrap">Doenças&nbsp;Agudas&nbsp;Transmissíveis-NDAT-Divisão&nbsp;de&nbsp;Vigilância&nbsp;Epidemiológica&nbsp;(DVE)&nbsp;/</td><td class="diff_next"></td><td class="diff_header" id="to16_131">131</td><td nowrap="nowrap">Doenças&nbsp;Agudas&nbsp;Transmissíveis-NDAT-Divisão&nbsp;de&nbsp;Vigilância&nbsp;Epidemiológica&nbsp;(DVE)&nbsp;/</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_136">136</td><td nowrap="nowrap">COVISA.</td><td class="diff_next"></td><td class="diff_header" id="to16_132">132</td><td nowrap="nowrap">COVISA.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_137">137</td><td nowrap="nowrap">Brasil.&nbsp;Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Profilaxia&nbsp;Pré-Exposição</td><td class="diff_next"></td><td class="diff_header" id="to16_133">133</td><td nowrap="nowrap">Brasil.&nbsp;Protocolo&nbsp;Clínico&nbsp;e&nbsp;Diretrizes&nbsp;Terapêuticas&nbsp;para&nbsp;Profilaxia&nbsp;Pré-Exposição</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__8"></td><td class="diff_header" id="from16_138">138</td><td nowrap="nowrap">(PrEP)&nbsp;de&nbsp;Risco&nbsp;à&nbsp;Infecção&nbsp;pelo&nbsp;HIV.&nbsp;Ministério&nbsp;da&nbsp;Saúde:&nbsp;Brasília,&nbsp;1ª&nbsp;edição,&nbsp;2022.</td><td class="diff_next"></td><td class="diff_header" id="to16_134">134</td><td nowrap="nowrap">(PrEP)&nbsp;de&nbsp;Risco&nbsp;à&nbsp;Infecção&nbsp;pelo&nbsp;HIV.&nbsp;Ministério&nbsp;da&nbsp;Saúde:&nbsp;Brasília,&nbsp;1ª&nbsp;edição,&nbsp;2022.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__8">n</a></td><td class="diff_header" id="from16_139">139</td><td nowrap="nowrap"><span class="diff_sub">Disponível&nbsp;em:&nbsp;&lt;https://www.gov.br/aids/pt-br/central-de-conteudo/pcdts/2017/hiv-</span></td><td class="diff_next"><a href="#difflib_chg_to16__8">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__9"></td><td class="diff_header" id="from16_140">140</td><td nowrap="nowrap">aids/pcdt-prep-versao-eletronica-22_09_2022.pdf/view&gt;&nbsp;Acesso&nbsp;em:&nbsp;08/01/2025.</td><td class="diff_next"></td><td class="diff_header" id="to16_135">135</td><td nowrap="nowrap">aids/pcdt-prep-versao-eletronica-22_09_2022.pdf/view&gt;&nbsp;Acesso&nbsp;em:&nbsp;08/01/2025.</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_141">141</td><td nowrap="nowrap">Brasil.&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imunobiológicos&nbsp;Especiais.&nbsp;Ministério</td><td class="diff_next"></td><td class="diff_header" id="to16_136">136</td><td nowrap="nowrap">Brasil.&nbsp;Manual&nbsp;dos&nbsp;Centros&nbsp;de&nbsp;Referência&nbsp;para&nbsp;Imunobiológicos&nbsp;Especiais.&nbsp;Ministério</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_142">142</td><td nowrap="nowrap">da&nbsp;Saúde:&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde&nbsp;e&nbsp;Ambiente.&nbsp;Brasília:&nbsp;2023.&nbsp;Disponível</td><td class="diff_next"></td><td class="diff_header" id="to16_137">137</td><td nowrap="nowrap">da&nbsp;Saúde:&nbsp;Secretaria&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde&nbsp;e&nbsp;Ambiente.&nbsp;Brasília:&nbsp;2023.&nbsp;Disponível</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__9">n</a></td><td class="diff_header" id="from16_143">143</td><td nowrap="nowrap"><span class="diff_sub">em:&nbsp;&lt;https://sbim.org.br/images/calendarios/manual-dos-centros-de-referencia-</span></td><td class="diff_next"><a href="#difflib_chg_to16__9">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__10"></td><td class="diff_header" id="from16_144">144</td><td nowrap="nowrap">para-imunobiologicos-especiais-6a-edicao-2023.pdf&gt;&nbsp;Acesso&nbsp;em:&nbsp;08/01/2025.</td><td class="diff_next"></td><td class="diff_header" id="to16_138">138</td><td nowrap="nowrap">para-imunobiologicos-especiais-6a-edicao-2023.pdf&gt;&nbsp;Acesso&nbsp;em:&nbsp;08/01/2025.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__10">n</a></td><td class="diff_header" id="from16_145">145</td><td nowrap="nowrap"><span class="diff_sub">Documento&nbsp;assinado&nbsp;eletronicamente&nbsp;por&nbsp;Eder&nbsp;Gatti&nbsp;Fernandes,&nbsp;Diretor(a)&nbsp;do</span></td><td class="diff_next"><a href="#difflib_chg_to16__10">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_146">146</td><td nowrap="nowrap">13:55,&nbsp;conforme&nbsp;horário&nbsp;oficial&nbsp;de&nbsp;Brasília,&nbsp;com&nbsp;fundamento&nbsp;no&nbsp;§&nbsp;3º,&nbsp;do&nbsp;art.&nbsp;4º,&nbsp;do</td><td class="diff_next"></td><td class="diff_header" id="to16_139">139</td><td nowrap="nowrap">13:55,&nbsp;conforme&nbsp;horário&nbsp;oficial&nbsp;de&nbsp;Brasília,&nbsp;com&nbsp;fundamento&nbsp;no&nbsp;§&nbsp;3º,&nbsp;do&nbsp;art.&nbsp;4º,&nbsp;do</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_147">147</td><td nowrap="nowrap">Decreto&nbsp;nº&nbsp;10.543,&nbsp;de&nbsp;13&nbsp;de&nbsp;novembro&nbsp;de&nbsp;2020;&nbsp;e&nbsp;art.&nbsp;8º,&nbsp;da&nbsp;Portaria&nbsp;nº&nbsp;900&nbsp;de&nbsp;31</td><td class="diff_next"></td><td class="diff_header" id="to16_140">140</td><td nowrap="nowrap">Decreto&nbsp;nº&nbsp;10.543,&nbsp;de&nbsp;13&nbsp;de&nbsp;novembro&nbsp;de&nbsp;2020;&nbsp;e&nbsp;art.&nbsp;8º,&nbsp;da&nbsp;Portaria&nbsp;nº&nbsp;900&nbsp;de&nbsp;31</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_148">148</td><td nowrap="nowrap">de&nbsp;Março&nbsp;de&nbsp;2017.</td><td class="diff_next"></td><td class="diff_header" id="to16_141">141</td><td nowrap="nowrap">de&nbsp;Março&nbsp;de&nbsp;2017.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__11"><a href="#difflib_chg_to16__11">n</a></td><td class="diff_header" id="from16_149">149</td><td nowrap="nowrap"><span class="diff_sub">Documento&nbsp;assinado&nbsp;eletronicamente&nbsp;por&nbsp;Mariângela&nbsp;Batista&nbsp;Galvão&nbsp;Simão,</span></td><td class="diff_next"><a href="#difflib_chg_to16__11">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_150">150</td><td nowrap="nowrap">Secretário(a)&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde&nbsp;e&nbsp;Ambiente,&nbsp;em&nbsp;28/04/2025,&nbsp;às&nbsp;17:50,</td><td class="diff_next"></td><td class="diff_header" id="to16_142">142</td><td nowrap="nowrap">Secretário(a)&nbsp;de&nbsp;Vigilância&nbsp;em&nbsp;Saúde&nbsp;e&nbsp;Ambiente,&nbsp;em&nbsp;28/04/2025,&nbsp;às&nbsp;17:50,</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_151">151</td><td nowrap="nowrap">conforme&nbsp;horário&nbsp;oficial&nbsp;de&nbsp;Brasília,&nbsp;com&nbsp;fundamento&nbsp;no&nbsp;§&nbsp;3º,&nbsp;do&nbsp;art.&nbsp;4º,&nbsp;do&nbsp;Decreto</td><td class="diff_next"></td><td class="diff_header" id="to16_143">143</td><td nowrap="nowrap">conforme&nbsp;horário&nbsp;oficial&nbsp;de&nbsp;Brasília,&nbsp;com&nbsp;fundamento&nbsp;no&nbsp;§&nbsp;3º,&nbsp;do&nbsp;art.&nbsp;4º,&nbsp;do&nbsp;Decreto</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_152">152</td><td nowrap="nowrap">nº&nbsp;10.543,&nbsp;de&nbsp;13&nbsp;de&nbsp;novembro&nbsp;de&nbsp;2020;&nbsp;e&nbsp;art.&nbsp;8º,&nbsp;da&nbsp;Portaria&nbsp;nº&nbsp;900&nbsp;de&nbsp;31&nbsp;de</td><td class="diff_next"></td><td class="diff_header" id="to16_144">144</td><td nowrap="nowrap">nº&nbsp;10.543,&nbsp;de&nbsp;13&nbsp;de&nbsp;novembro&nbsp;de&nbsp;2020;&nbsp;e&nbsp;art.&nbsp;8º,&nbsp;da&nbsp;Portaria&nbsp;nº&nbsp;900&nbsp;de&nbsp;31&nbsp;de</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_153">153</td><td nowrap="nowrap">Março&nbsp;de&nbsp;2017.</td><td class="diff_next"></td><td class="diff_header" id="to16_145">145</td><td nowrap="nowrap">Março&nbsp;de&nbsp;2017.</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__12">n</a></td><td class="diff_header" id="from16_154">154</td><td nowrap="nowrap"><span class="diff_sub">Nota&nbsp;Técnica&nbsp;Conjunta&nbsp;184&nbsp;(0047447082)&nbsp;SEI&nbsp;25000.061286/2025-97&nbsp;/&nbsp;pg.&nbsp;4</span></td><td class="diff_next"><a href="#difflib_chg_to16__12">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_155">155</td><td nowrap="nowrap"><span class="diff_sub">Documento&nbsp;assinado&nbsp;eletronicamente&nbsp;por&nbsp;Draurio&nbsp;Barreira&nbsp;Cravo&nbsp;Neto,</span></td><td class="diff_next"></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_156">156</td><td nowrap="nowrap">Diretor(a)&nbsp;do&nbsp;Departamento&nbsp;de&nbsp;HIV/AIDS,&nbsp;Tuberculose,&nbsp;Hepatites&nbsp;Virais&nbsp;e</td><td class="diff_next"></td><td class="diff_header" id="to16_146">146</td><td nowrap="nowrap">Diretor(a)&nbsp;do&nbsp;Departamento&nbsp;de&nbsp;HIV/AIDS,&nbsp;Tuberculose,&nbsp;Hepatites&nbsp;Virais&nbsp;e</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__12"></td><td class="diff_header" id="from16_157">157</td><td nowrap="nowrap">Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;em&nbsp;29/04/2025,&nbsp;às&nbsp;10:52,&nbsp;conforme</td><td class="diff_next"></td><td class="diff_header" id="to16_147">147</td><td nowrap="nowrap">Infecções&nbsp;Sexualmente&nbsp;Transmissíveis,&nbsp;em&nbsp;29/04/2025,&nbsp;às&nbsp;10:52,&nbsp;conforme</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_158">158</td><td nowrap="nowrap">horário&nbsp;oficial&nbsp;de&nbsp;Brasília,&nbsp;com&nbsp;fundamento&nbsp;no&nbsp;§&nbsp;3º,&nbsp;do&nbsp;art.&nbsp;4º,&nbsp;do&nbsp;Decreto&nbsp;nº</td><td class="diff_next"></td><td class="diff_header" id="to16_148">148</td><td nowrap="nowrap">horário&nbsp;oficial&nbsp;de&nbsp;Brasília,&nbsp;com&nbsp;fundamento&nbsp;no&nbsp;§&nbsp;3º,&nbsp;do&nbsp;art.&nbsp;4º,&nbsp;do&nbsp;Decreto&nbsp;nº</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_159">159</td><td nowrap="nowrap">10.543,&nbsp;de&nbsp;13&nbsp;de&nbsp;novembro&nbsp;de&nbsp;2020;&nbsp;e&nbsp;art.&nbsp;8º,&nbsp;da&nbsp;Portaria&nbsp;nº&nbsp;900&nbsp;de&nbsp;31&nbsp;de&nbsp;Março</td><td class="diff_next"></td><td class="diff_header" id="to16_149">149</td><td nowrap="nowrap">10.543,&nbsp;de&nbsp;13&nbsp;de&nbsp;novembro&nbsp;de&nbsp;2020;&nbsp;e&nbsp;art.&nbsp;8º,&nbsp;da&nbsp;Portaria&nbsp;nº&nbsp;900&nbsp;de&nbsp;31&nbsp;de&nbsp;Março</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_160">160</td><td nowrap="nowrap">de&nbsp;2017.</td><td class="diff_next"></td><td class="diff_header" id="to16_150">150</td><td nowrap="nowrap">de&nbsp;2017.</td></tr>
            <tr><td class="diff_next" id="difflib_chg_to16__13"></td><td class="diff_header" id="from16_161">161</td><td nowrap="nowrap">acao=documento_conferir&amp;id_orgao_acesso_externo=0,&nbsp;informando&nbsp;o&nbsp;código</td><td class="diff_next"></td><td class="diff_header" id="to16_151">151</td><td nowrap="nowrap">acao=documento_conferir&amp;id_orgao_acesso_externo=0,&nbsp;informando&nbsp;o&nbsp;código</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__13">n</a></td><td class="diff_header" id="from16_162">162</td><td nowrap="nowrap"><span class="diff_sub">verificador&nbsp;0047447082&nbsp;e&nbsp;o&nbsp;código&nbsp;CRC&nbsp;E0772D74.</span></td><td class="diff_next"><a href="#difflib_chg_to16__13">n</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_163">163</td><td nowrap="nowrap">Referência:&nbsp;Processo&nbsp;nº&nbsp;25000.061286/2025-97&nbsp;SEI&nbsp;nº&nbsp;0047447082</td><td class="diff_next"></td><td class="diff_header" id="to16_152">152</td><td nowrap="nowrap">Referência:&nbsp;Processo&nbsp;nº&nbsp;25000.061286/2025-97&nbsp;SEI&nbsp;nº&nbsp;0047447082</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_164">164</td><td nowrap="nowrap">SRTVN&nbsp;702,&nbsp;Via&nbsp;W5&nbsp;Norte&nbsp;Edifício&nbsp;PO700,&nbsp;6º&nbsp;andar&nbsp;-&nbsp;Bairro&nbsp;Asa&nbsp;Norte,&nbsp;Brasília/DF,&nbsp;CEP&nbsp;70719-040</td><td class="diff_next"></td><td class="diff_header" id="to16_153">153</td><td nowrap="nowrap">SRTVN&nbsp;702,&nbsp;Via&nbsp;W5&nbsp;Norte&nbsp;Edifício&nbsp;PO700,&nbsp;6º&nbsp;andar&nbsp;-&nbsp;Bairro&nbsp;Asa&nbsp;Norte,&nbsp;Brasília/DF,&nbsp;CEP&nbsp;70719-040</td></tr>
            <tr><td class="diff_next"></td><td class="diff_header" id="from16_165">165</td><td nowrap="nowrap">Site&nbsp;-&nbsp;saude.gov.br</td><td class="diff_next"></td><td class="diff_header" id="to16_154">154</td><td nowrap="nowrap">Site&nbsp;-&nbsp;saude.gov.br</td></tr>
            <tr><td class="diff_next"><a href="#difflib_chg_to16__top">t</a></td><td class="diff_header" id="from16_166">166</td><td nowrap="nowrap"><span class="diff_sub">Nota&nbsp;Técnica&nbsp;Conjunta&nbsp;184&nbsp;(0047447082)&nbsp;SEI&nbsp;25000.061286/2025-97&nbsp;/&nbsp;pg.&nbsp;5</span></td><td class="diff_next"><a href="#difflib_chg_to16__top">t</a></td><td class="diff_header"></td><td nowrap="nowrap"></td></tr>
        </tbody>
    </table>
    <table class="diff" summary="Legends">
        <tr> <th colspan="2"> Legends </th> </tr>
        <tr> <td> <table border="" summary="Colors">
                      <tr><th> Colors </th> </tr>
                      <tr><td class="diff_add">&nbsp;Added&nbsp;</td></tr>
                      <tr><td class="diff_chg">Changed</td> </tr>
                      <tr><td class="diff_sub">Deleted</td> </tr>
                  </table></td>
             <td> <table border="" summary="Links">
                      <tr><th colspan="2"> Links </th> </tr>
                      <tr><td>(f)irst change</td> </tr>
                      <tr><td>(n)ext change</td> </tr>
                      <tr><td>(t)op</td> </tr>
                  </table></td> </tr>
    </table>
</body>

</html>